Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis

Hepatology Research

Volumn 38, Issue 1, 2008, Pages 1-26

  Kasprzak, Aldona ^a   Adamek, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Chronic hepatitis C; Hepatocarcinogenesis; Oncogenic proteins; Subcellular localization

Indexed keywords

ALPHA INTERFERON; CORE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; CYTOKINE; GROWTH FACTOR; HEPATITIS C VIRUS PROTEIN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5A; ONCOPROTEIN; PROTEIN P21; PROTEIN P53; PROTEIN P73; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; CELL CYCLE REGULATION; CELL DEATH; CELL FUNCTION; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHRONIC HEPATITIS; DRUG MECHANISM; FATTY LIVER; GENE MUTATION; GENE TARGETING; GENE TRANSLOCATION; GENOTYPE; HEPATITIS C; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RISK FACTOR; VIRUS REPLICATION;

EID: 36549068334     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00261.x     Document Type: Review

References (201)

1. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis 2000; 20: 17-35.
3. Di Bisceglie AM. Hepatitis C. Lancet 1998; 351: 351-5.
4. Murphy FA, Fauguet CM, Bishop DHL et al. Classification and Nomenclature of Viruses: Sixth Report of the International Committee on Taxonomy of Viruses. Vienna: Springer, 1995; 424-6.
5. Choo QL, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-5.
6. Shimizu YK, Feinstone SM, Kohara M, Purcell RH, Yoshikura H. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy. Hepatology 1996; 23: 205-9.
7. Grakoui A, McCourt DW, Wychowski C, Feinstone SM, Rice CM. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polycore protein leavage sites. J Virol 1993; 67: 2832-43.
8. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM. Expression and identification of hepatitis C virus polycore protein leavage products. J Virol 1993; 67: 1385-95.
9. Kato N, Hujikata M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome form Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524-8.
10. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J Virol 1994; 68: 5063-73.
11. Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527-38.
12. Okamoto H, Kurai K, Okada SI et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes. Virology 1992; 188: 331-41.
13. Anzola M. Hepatocellular carcinoma: Role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 2004; 11: 383-93.
14. Lindenbach BD, Rice CM. Flaviviridae: The viruses and their replication. In: Knipe D, Howley PM etal., eds. Fields Virology, Vol. 1. Philadelphia, PA: Lippincott Williams & Wilkins, 2001; 991-1041.
15. Suzuki R, Suzuki T, Ishii K, Matsuura Y, Miyamura T. Processing and functions of hepatitis C virus proteins. Intervirology 1999; 42: 145-52.
16. Harada S, Watanabe Y, Takeuchi K et al. Expression of processed core protein of hepatitis C virus in mammalian cells. J Virol 1991; 65: 3015-21.
17. Roussel J, Pillez A, Montpellier C et al. Characterization of the expression of the hepatitis C virus F protein. J Gen Virol 2003; 84: 1751-9.
18. Xu Z, Choi J, Lu W, Ou JH. Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J Virol 2003; 77: 1578-83.
19. Santolini E, Migliaccio G, La-Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol 1994; 68: 3631-41.
20. Egger D, Wolk B, Gosert R et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 2002; 76: 5974-84.
21. Yagi S, Mori K, Tanaka E et al. Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients. J Med Virol 2005; 77: 399-413.
22. Robertson B, Myers G, Howard C et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standarization. Arch Virol 1998; 143: 2493-503.
23. Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J Clin Microbiol 2002; 40: 3625-30.
24. Ogata S, Ku Y, Yoon S, Makino S, Nagano-Fujii M, Hotta H. Correlation between secondary structure of an amino-terminal portion of the nonstructural protein 3 (NS3) of hepatitis C virus and development of hepatocellular carcinoma. Microbiol Immunol 2002; 46: 549-54.
25. Ogata S, Florese RH, Nagano-Fujii M et al. Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein. J Clin Microbiol 2003; 41: 2835-41.
26. Brechot C. Hepatitis C virus: Molecular biology and genetic variability. In: Schmid R, Blum HE, Maier KP, Bianchi L, Gerok W, Stalder GA, eds. Acute and Chronic Liver Diseases: Molecular Biology and Clinics. Dordrecht: Kluwer Academic Publisher, 1996; 35-56.
27. Colombo M. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 1999; 19: 263-9.
28. Lowes KN, Croager EJ, Abraham LJ, Olnyk JK, Yeoh GCT. Upregulation of lymphotoxin b expression in liver progenitor (oval) cells in chronic hepatitis C. Gut 2003; 52: 1327-32.
29. Xiao J-C, Jin X-L, Ruck P, Adam A, Kaiserling E. Hepatic progenitor cells in human liver cirrhosis: Immunocytochemical, electron microscopic and immunofluorescence confocal microscopic findings. World J Gastrwwwoenterol 2004; 10: 1208-11.
30. Barber GN, Wambach M, Thompson S et al. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol 1995; 15: 3138-46.
31. Gale M Jr, Blakely CM, Kwieciszewski B et al. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation. J Virol 1998; 18: 5208-18.
32. Gale M Jr, Kwieciszewski B, Dosset M, Nakao H, Katze MG. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 1999; 73: 6506-16.
33. Shimada A, Shiota G, Miyata H et al. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res 1998; 58: 4434-8.
34. Hiasa Y, Kamegaya Y, Nuriya H et al. Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol 2003; 98: 2528-34.
35. Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995; 96: 224-30.
36. Enomoto N, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77-81.
37. Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 1999; 162: 4177-83.
38. De Lucas S, Bartolome J, Carreno V. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J Infect Dis 2005; 191: 93-9.
39. Hiramatsu A, Gotoh B, Fujii Y, Yoshida T, Chayama K, Sakaguchi T. Suppression of interferon-related promoter activation by hepatitis C virus proteins expressed in cultured cells. Hiroshima J Med Sci 2006; 55: 71-7.
40. Dansako H, Naganuma A, Nakamura T, Ikeda F, Nozaki A, Kato N. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element. Virus Res 2003; 97: 17-30.
41. Huang H, Fujii H, Sankila A et al. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 1999; 155: 1795-801.
42. Wang F, Yoshida I, Takamatsu M, Fujita T, Oka K, Hotta H. Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1. Biochem Biophys Res Commun 2000; 273: 479-84.
43. Errington W, Wardell AD, McDonald S, Goldin RD, McGarvey MJ. Subcellular localisation of NS3 in HCV-infected hepatocytes. J Med Virol 1999; 59: 456-62.
44. Falcon V, Acosta-Rivero N, Chinea G et al. Ultrastructural evidences of HCV infection in hepatocytes of chronically HCV-infected patients. Biomed Biophys Res Commun 2003; 305: 1085-90.
45. Kaito M, Watanabe S, Tsukiyama-Kohara K et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994; 75: 1755-60.
46. Moradpour D, Englert C, Wakita T, Wands JR. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996; 222: 51-63.
47. Moradpour D, Wakita T, Wands JR, Blum HE. Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. Biochem Biophys Res Commun 1998; 246: 920-4.
48. Mottola G, Cardinali G, Ceccacci A et al. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 2002; 293: 31-43.
49. Nielsen SU, Bassendine MF, Burt AD, Bevitt DJ, Toms GL. Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. J Gen Virol 2004; 85: 1497-507.
50. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-13.
51. Rouille Y, Helle F, Delgrange D et al. Subcellular localization of hepatitis C structural proteins in a cell culture system that efficiently replicates the virus. J Virol 2006; 80: 2832-41.
52. Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005; 102: 9294-9.
53. Heller T, Saito S, Auerbach J et al. An in vitro model of hepatitis C virion production. Proc Natl Acad Sci USA 2005; 102: 2579-83.
54. Uprichard SL, Chung J, Chisari FV, Wakita T. Replication of a hepatitis C virus replicon clone in mouse cells. J Virol 2006; 3: 89, 10.1 186/ 1743-422X-3-89.
55. Lee MN, Jung EY, Kwun HJ et al. Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-beta pathway. J Gen Virol 2002; 83: 2145-51.
56. Hassan M, Ghozlan H, Abdel-Kader O. Activation of RB/E2F signalling pathway is regulated for the modulation of hepatitis C virus core protein-induced cell growth in liver and non-liver cells. Cell Signal 2004; 16: 1375-85.
57. Lu W, Lo SY, Chen M, Wu KJ, Fung YKT, Ou JH. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 1999; 264: 134-41.
58. Otsuka M, Kato N, Lan KH et al. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000; 275: 34122-30.
59. Siavoshian S, Abraham JD, Kieny MP, Schuster C. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol 2004; 149: 323-36.
60. Yamanaka T, Kodama T, Doi T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun 2002; 294: 528-34.
61. Kao CF, Chen SY, Chen JY, Lee YHW. Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 2004; 23: 2472-83.
62. Dubourdeau M, Miyamura T, Matsuura Y, Alric L, Pipy B, Rousseau D. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21 (WAF1) down-regulation-effect of transforming growth factor beta. J Hepatol 2002; 37: 486-92.
63. Han HJ, Jung EY, Lee WJ, Jang KL. Cooperative regression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett 2002; 518: 169-72.
64. Jung EY, Lee MN, Yang HY, Yu D, Jang KL. The repressive activity of hepatitis C virus core protein on the transcription of p21 (waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res 2001; 79: 109-15.
65. Ray RB, Steele R, Meyer K, Ray R. Hepatitis C virus core protein represses p21/WAF1/Cip1/Sid1 promoter activity. Gene 1998; 208: 331-6.
66. Kwun HJ, Jang KL. Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene. J Viral Hepat 2003; 10: 249-55.
67. Aoki H, Hayashi J, Moriyama M, Arkawa Y, Hino O. Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol 2000; 74: 1736-41.
68. Cho JW, Baek WK, Suh SI et al. Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver 2001; 21: 137-42.
69. Alisi A, Giambartolomei S, Cupelli F et al. Physical and functional interaction between HCV core protein and the different p73 isoforms. Oncogene 2003; 22: 2573-80.
70. Hahn CS, Cho YG, Kang B-S, Lester IM, Hahn YS. The core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 2000; 276: 127-37.
71. Zhu N, Khoshnan A, Schneider R et al. Hepatitis C virus core protein binds to the cytoplasmic tail of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 1998; 72: 3691-7.
72. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwaland BB, Ray R. Inhibition of tumor necrosis factor (TNF-alpha) -mediated apoptosis by hepatitis C virus core protein. J Biol Chem 1998; 273: 2256-9.
73. Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol 2006; 80: 4372-9.
74. Dumoulin FL, van dem Bussche A, Sohne J, Sauerbruch T, Spengler U. Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells. Eur J Clin Invest 1999; 29: 940-6.
75. Zhu N, Ware CF, Lai MM. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signalling of tumor necrosis factor receptor. Virology 2001; 283: 178-87.
76. You LR, Chen CM, Lee YH. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 1999; 73: 1672-81.
77. Honda M, Kaneko S, Shimazaki T et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stable transformed Chinese hamster ovary cells. Hepatology 2000; 31: 1351-9.
78. Hara Y, Hino K, Okuda M et al. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J Gastroenterol 2006; 41: 257-68.
79. Kim DW, Suzuki R, Harada T, Saito I, Miyamura T. Trans-suppression of gene expression by hepatitis C viral core protein. Jpn J Med Sci Biol 1994; 47: 211-20.
80. Erhardt A, Hassan M, Heintges T, Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002; 292: 272-84.
81. Park KJ, Choi SH, Koh MS et al. Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2. Virus Res 2001; 74: 89-98.
82. Ray RB, Lagging LM, Meyer K. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996; 70: 4438-43.
83. Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 1998; 72: 3060-5.
84. Ray RB, Lagging LM, Meyer K, Steele R, Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 1995; 37: 209-20.
85. Cho J, Baek W, Yang S, Chang J, Sung YC, Suh M. HCV core protein modulates Rb pathway throug pRb down regulation and E2F-1 up-regulation. Biochim Biophys Acta 2001; 1538: 59-66.
86. Sato Y, Kato J, Takimoto R etal. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB. Gut 2006; 55: 1801-8.
87. Soo HM, Garzino-Demo A, Hong W et al. Expression of full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 2002; 303: 253-77.
88. Liao QJ, Ye LB, Timani KA et al. Hepatitis C virus non-structural 5A core proteinan enhance full-length core protein-induced nuclear factor-kappaB activation. World J Gastroenterol 2005; 11: 6433-9.
89. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses Interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem 2004; 279: 43479-86.
90. Jin DY, Wang HL, Zhou Y et al. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J 2000; 19: 729-40.
91. Hsieh TY, Matsumoto M, Chou HC et al. Hepatitis C virus core protein interacts with heterogenous nuclear ribonucleoprotein K. J Biol Chem 1998; 273: 17651-9.
92. Yoshida T, Hanada T, Tokuhisa T et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 2002; 196: 641-53.
93. Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 2002; 298: 53-62.
94. Hosui A, Ohkawa K, Ishida H et al. Hepatitis C virus core protein differently regulates the JAK-STAT signalling pathway under interleukin-6 and interferon gamma stimuli. J Biol Chem 2003; 278: 28562-71.
95. Taniguchi H, Kato N, Otsuka M et al. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. J Med Virol 2004; 72: 52-9.
96. Matsumoto M, Hsieh TY, Zhu N et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J Virol 1997; 71: 1301-9.
97. Chen CM, You LR, Hwang LH, Lee YHW. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor. J Virol 1997; 71: 9417-26.
98. Hayashi J, Aoki H, Kajino K, Moriyama M, Arakawa Y, Hino O. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor of transforming growth factor alpha. Hepatology 2000; 32: 958-61.
99. Yan XB, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N. Mapping of interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR. Virus Res 2007; 125: 79-87.
100. You LR, Chen CM, Yeh TS et al. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 1999; 73: 2841-53.
101. Owsianka AM, Patel AH. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 1999; 257: 330-40.
102. Sabile A, Perlemuter G, Bono F et al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 1999; 30: 1064-76.
103. Barba G, Harper F, Harada T et al. Hepatitis C virus core protein shows a cytoplasmic localisation and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997; 94: 1200-5.
104. Chen SY, Kao CF, Chen CM et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 2003; 278: 591-607.
105. Shih CM, Chen CM, Chen SY, Lee YHW. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 1995; 69: 1160-71.
106. Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000; 106: 1239-49.
107. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by the in vitro processing analysis. Proc Natl Acad Sci USA 1991; 88: 5547-51.
108. Matsumoto M, Hwang SB, Jeng KS, Zhu N, Lai M. Homotyping interaction and multimerization of hepatitis C virus core protein. Virology 1996; 218: 43-51.
109. Shimoike T, Mimori S, Tani H, Matsuura Y, Miyamura T. Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol 1999; 73: 9718-25.
110. Liu Q, Tackney C, Bhat RA, Prince AM, Zhang P. Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol 1997; 71: 657-62.
111. Lo SY, Selby M, Tong M, Ou JH. Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution. Virology 1994; 199: 124-31.
112. Suzuki R, Tamura K, Li J et al. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology 2001; 280: 301-9.
113. Yasui K, Wakita T, Tsukijama-Kohara K et al. The native form and maturation process of hepatitis C virus core protein. J Virol 1998; 72: 6048-55.
114. Yamanaka T, Uchida M, Doi T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem Biophys Res Commun 2002; 294: 521-7.
115. Martire G, Viola A, Iodice L, Lotti LV, Gradini R, Bonatti S. Hepatitis C structural proteins reside in the endoplasmic reticulum as well as in the intermediate compartment/cis-Golgi complex region of stable transfected cells. Virology 2001; 280: 176-82.
116. Mizuno M, Yamada G, Tanaka T, Shimotohno K, Takatani M, Tsuji T. Virion-like structures in HeLa G cells transfected with the full-length sequence of the hepatitis C virus genome. Gastroenterology 1995; 109: 1933-40.
117. Suzuki R, Sakamoto S, Tsutsumi T et al. Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 2005; 79: 1271-81.
118. Yap SH, Willems M, Van den Oord J et al. Detection of hepatitis C virus antigen by immuno-histochemical staining: A histological marker of hepatitis C virus infection. J Hepatol 1994; 20: 275-81.
119. Kim JE, Song WK, Chung KM, Back SH, Jang SK. Subcellular localization of hepatitis C viral proteins in mammalian cells. Arch Virol 1999; 144: 329-43.
120. Chang SC, Yen JH, Kang HY, Jang MH, Chang MF. Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 1994; 205: 1284-90.
121. Suzuki R, Matsuura Y, Suzuki T et al. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 1995; 76: 53-61.
122. Walker FM, Dazza MC, Dauge MC et al. Detection and localization by in situ molecular biology techniques and immunohistochemistry of hepatitis C virus in livers of chronically infected patients. J Histochem Cytochem 1998; 46: 653-60.
123. Kasprzak A, Seidel J, Biczysko W, Wysocki J, Spachacz R, Zabel M. Intracellular localization of hepatitis C virus proteins (NS3 and C) in children with chronic hepatitis C. Liver Int 2005; 25: 896-903.
124. Moriya K, Yotsuyanagi H, Shintani Y et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527-31.
125. Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 1997; 272: 10983-6.
126. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YHW. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 5823-32.
127. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
128. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994; 54: 231-5.
129. Ozaki T, Nakagawara A. p73, a sophisticated p53 family member in the cancer world. Cancer Sci 2005; 96: 729-37.
130. Rubbia-Brandt L, Quadri R, Abid K et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33: 106-15.
131. Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007; 109: 2490-6.
132. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007; 355: 883-8.
133. Romero-Gomez M. Insulin resistance and hepatitis C. World J Gastroenterol 2006; 12: 7075-80.
134. Hourioux C, Patient R, Morin A et al. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 2007; 56: 1302-8.
135. Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology 2002; 36: 1266-72.
136. Castera L. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Minerva Gastroenterol Dietol 2006; 52: 125-34.
137. Conjeevaram HS, Kleiner DE, Everhart JE et al. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007; 45: 80-7.
138. Decock S, Verslype C, Fevery J. Hepatitis C and insulin resistance: mutual interactions. A review. Acta Clin Belg 2007; 62: 111-19.
139. Okuda M, Li K, Beard MR et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-75.
140. Schwer B, Ren S, Pietschmann T et al. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 2004; 78: 7958-68.
141. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-7.
142. Korenaga M, Wang T, Li Y et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005; 280: 37481-8.
143. Wang T, Weinman SA. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J Gastroenterol Hepatol 2006; 21 (Suppl 3): S34-7.
144. Otani K, Korenaga M, Beard MR et al. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxity in hepatoma cells. Gastroenterology 2005; 128: 96-107.
145. Fujita T, Ishido S, Muramatsu S, Itoh M, Hotta H. Suppression of actinomycin d -induced apoptosis by the NS3 protein of hepatitis C virus. Biochem Biophys Res Commun 1996; 229: 825-31.
146. Ishido S, Fujita T, Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem Biophys Res Commun 1998; 244: 35-40.
147. Tanaka M, Nagano-Fujii M, Deng L, Ishido S, Sada K, Hotta H. Single-point mutations of hepatitis C virus NS3 that impair p53 interaction and anti-apoptotic activity of NS3. Biochem Biophys Res Commun 2006; 340: 792-9.
148. Kwun HJ, Jung EY, Ahn JY, Lee MN, Jang KL. p53-dependent transcriptional repression of p21 (waf1) by hepatitis C virus NS3. J Gen Virol 2001; 82: 2235-41.
149. Prikhod'ko EA, Prikhod'ko GG, Siegel RM, Thompson P, Major ME, Cohen JI. The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities. Virology 2004; 329: 53-67.
150. Hassan M, Ghozlan H, Abdel-Kader O. Activation of c-Jun NH2-terminal kinase (JNK) signalling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3) -mediated cell growth. Virology 2005; 333: 324-36.
151. Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O. Induction of high-molecular weight (HMW) tumor necrosis factor (TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation. Cell Signal 2007; 19: 301-11.
152. Bataller R, Paik YH, Lindquist JN, Lemasters JJ, Brenner DA. Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells. Gastroenterology 2004; 126: 529-40.
153. Schulze-Krebs A, Preimel D, Popov Y et al. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroentrology 2005; 129: 246-58.
154. Borowski P, Oehlmann K, Heiland M, Laufs R. Nonstructural protein 3 of hepatitis C virus block the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase. J Virol 1997; 71: 2838-43.
155. Feng D, Cheng R, Ouyang X, Zheng H, Tsutomu T. Hepatitis C virus nonstructural protein NS (3) and telomerase activity. Chin Med J 2002; 115: 597-602.
156. Feng DY, Sun Y, Cheng RX, Ouyang XM, Zheng H. Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol 2005; 11: 2157-61.
157. Gallinari P, Brennan D, Nardi C et al. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol 1998; 72: 6758-69.
158. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995; 69: 3893-6.
159. Zemel R, Gerechet S, Greif H et al. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat 2001; 8: 96-102.
160. De Francesco R, Pessi A, Steinkuhler C. The hepatitis C virus NS3 proteinase: Structure and function of zinc-containing serine proteinase. Antivir Ther 1998; 3 (Suppl 3): 99-109.
161. Lin C, Kim JL. Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J Virol 1999; 73: 8798-807.
162. Borowski P, Heiland M, Oehlmann K et al. Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem 1996; 237: 611-18.
163. Borowski P, Kuhl R, Laufs R, Schultze zur Wiesch J, Heiland M. Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus. J Clin Virol 1999; 13: 61-9.
164. Pang PS, Jankowsky E, Planet PJ, Pyle AM. The hepatitis C viral NS3 protein is a processive DNA helicase with cofactor enhanced RNA unwinding. EMBO J 2002; 21: 1168-76.
165. Lam AM, Keeney D, Frick DN. Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action. J Biol Chem 2003; 278: 44514-24.
166. Kuang WF, Lin YC, Jean F et al. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A. Biochem Biophys Res Commun 2004; 317: 211-17.
167. Muramatsu S, Ishido S, Fujita T, Itoh M, Hotta H. Nuclear localization of he NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 1997; 71: 4954-61.
168. Vallet S, Gouriou S, Nkontchou G et al. Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma? J Viral Hepat 2007; 14: 96-106.
169. He QQ, Cheng RX, Sun Y, Feng DY, Chen ZC, Zheng H. Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 c-terminal deleted protein. World J Gastroenterol 2003; 9: 474-8.
170. Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 2001; 75: 1401-7.
171. Lan KH, Sheu ML, Hwang SJ et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002; 21: 4801-11.
172. Quadri I, Iwahashi M, Simon F. Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 2002; 1592: 193-20.
173. Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999; 80: 1179-83.
174. Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R. Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. J Biol Chem 2001; 276: 12675-84.
175. Ghosh AK, Majumder M, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein protects against TNF-alpha mediated apoptotic cell death. Virus Res 2000; 67: 173-8.
176. Chung YL, Sheu ML, Yen SH. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer 2003; 107: 65-73.
177. Majumder M, Ghosh AK, Steele R et al. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by anti-FAS antibody, in transgenic mice. Virology 2002; 294: 94-105.
178. He Y, Nakao H, Tan SL et al. Subversion of cell signalling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and p85 phosphatidylinositol 3-kinase. J Virol 2002; 76: 9207-17.
179. Yeh CT, Chang MH, Shyu WC et al. Characterization of a HCV NS5A protein derived from patient with hepatoma. Biochem Biophys Res Commun 2005; 327: 516-22.
180. Girard S, Vossman E, Misek DE et al. Hepatitis C virus NS5A-regulated gene expression and signalling revealed via microarray and comparative promoter analyses. Hepatology 2004; 40: 708-18.
181. Bonte D, Francois C, Castelain S et al. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication. Arch Virol 2004; 149: 1353-71.
182. Street A, Macdonald A, McCormick C, Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular β-catenin and stimulation of β-catenin-responsive transcription. J Virol 2005; 79: 5006-16.
183. Macdonald A, Crowder K, Street A, McCormick C, Saksela K, Harris M. The hepatitis C virus non-structural NS5A protein inhibits activating protein-1 function by perturbing ras-ERK pathway signalling. J Biol Chem 2003; 278: 17775-84.
184. Choi SH, Hwang SB. Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein. J Biol Chem 2006; 281: 7468-78.
185. Polyak SJ, Khabar KS, Paschal DM et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001; 75: 6095-106.
186. Macdonald A, Crowder K, Street A, McCormick C, Harris M. The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 2004; 85: 721-9.
187. Sarcar B, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase. Virology 2004; 322: 51-60.
188. Kaneko T, Tanji Y, Satoh S et al. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 1994; 205: 320-6.
189. Reed KE, Gorbalenya AE, Rice CM. The NS5A/NS5 proteins of viruses from three genera of the family Flaviviridae are phosphorylated by associated serine/threonine kinases. J Virol 1998; 72: 6199-206.
190. Reyes GR. The nonstructural NS5A protein of hepatitis C virus: An expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci 2002; 9: 187-97.
191. Tanji Y, Kaneko T, Satoh S, Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 1995; 69: 3980-6.
192. Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease (s) in mammalian cells. Virology 2000; 10: 476-87.
193. Ide Y, Zhang L, Chen M et al. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 1996; 182: 203-11.
194. Shi ST, Polyak SJ, Tu H, Taylor DR, Gretch DR, Lai MM. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 2002; 292: 198-210.
195. Penin F, Brass V, Appel N et al. Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A. J Biol Chem 2004; 279: 40835-43.
196. Chung KM, Song OK, Jang SK. Hepatitis C nonstructural protein 5A contains potential transcriptional activator domains. Mol Cells 1997; 7: 661-7.
197. Kato N, Lan KH, Kioto Ono-Nita S, Shiratori Y, Omata M. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J Virol 1997; 71: 8856-9.
198. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 2000; 77: 1-24.
199. Conacci-Sorell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002; 109: 987-91.
200. Brillet R, Penin F, Hezode C, Chouteau P, Dhumeaux D, Pawlotsky JM. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region. J Infect Dis 2007; 195: 432-41.
201. Gimenez-Barcons M, Franco S, Suarez Y et al. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology 2001; 34: 158-67.